← Leaderboards
Andrew H Segal
Genitrix, Llc
$1,421,442
Attributed
$1,421,442
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $434.9K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$1,421,442 · 4
By mechanism
R44$846,110 · 1
R43$575,332 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseVaccine DevelopmentNeoplasm /Cancer VaccineHelper T LymphocyteTissue /Cell CultureCytotoxic T LymphocyteOpsoninEnzyme Linked Immunosorbent AssayDisease /Disorder ModelDrug Adverse EffectFlow CytometryGlycosylphosphatidylinositolsHemagglutininImmune ResponseImmunomodulatorsInterferon GammaMetalloendopeptidasesMolecular CloningNatural Killer CellsPolymerase Chain ReactionProtein EngineeringSialateT Cell ReceptorT Lymphocyte
Grant awards (5)
HA Based Opsonokines: A Novel Approach to Tumor Vaccines$411,180
R44 · FY2006 · CA · contact PI
HA Based Opsonokines: A Novel Approach to Tumor Vaccines$434,930
R44 · FY2005 · CA
HA Based Opsonokines:A Novel Approach to Tumor Vaccines$223,150
R43 · FY2004 · CA
DNA Vaccines for Anthrax: Targeting Afferent Immunity$148,163
R43 · FY2003 · AI
ENGINEERED OPSONINS FOR WHOLE CELL TUMOR VACCINES$204,019
R43 · FY2000 · CA